China Pharma Holdings (CPHI) Assets (2016 - 2025)
Historic Assets for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to $15.8 million.
- China Pharma Holdings' Assets rose 1737.15% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 1737.15%. This contributed to the annual value of $14.9 million for FY2024, which is 960.38% down from last year.
- Per China Pharma Holdings' latest filing, its Assets stood at $15.8 million for Q3 2025, which was up 1737.15% from $13.8 million recorded in Q2 2025.
- China Pharma Holdings' Assets' 5-year high stood at $22.6 million during Q4 2021, with a 5-year trough of $13.5 million in Q3 2024.
- Moreover, its 5-year median value for Assets was $16.2 million (2022), whereas its average is $16.9 million.
- In the last 5 years, China Pharma Holdings' Assets crashed by 2148.2% in 2022 and then soared by 1737.15% in 2025.
- Quarter analysis of 5 years shows China Pharma Holdings' Assets stood at $22.6 million in 2021, then dropped by 21.48% to $17.8 million in 2022, then dropped by 7.39% to $16.5 million in 2023, then fell by 9.6% to $14.9 million in 2024, then grew by 6.16% to $15.8 million in 2025.
- Its Assets was $15.8 million in Q3 2025, compared to $13.8 million in Q2 2025 and $14.2 million in Q1 2025.